Integrative genomic and functional profiling of the pancreatic cancer genome

被引:19
作者
Shain, A. Hunter [1 ]
Salari, Keyan [1 ,2 ]
Giacomini, Craig P. [1 ]
Pollack, Jonathan R. [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA
来源
BMC GENOMICS | 2013年 / 14卷
关键词
Pancreatic cancer; Functional genomics; RNAi screen; shRNA screen; NUP153; KLF5; K-RAS; CELL-LINES; RNA INTERFERENCE; OVARIAN-CANCER; BREAST-CANCER; SURVIVAL; GROWTH; FACTOR-5; TARGETS; GENES;
D O I
10.1186/1471-2164-14-624
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: Pancreatic cancer is a deadly disease with a five-year survival of less than 5%. A better understanding of the underlying biology may suggest novel therapeutic targets. Recent surveys of the pancreatic cancer genome have uncovered numerous new alterations; yet systematic functional characterization of candidate cancer genes has lagged behind. To address this challenge, here we have devised a highly-parallel RNA interference-based functional screen to evaluate many genomically-nominated candidate pancreatic cancer genes simultaneously. Results: For 185 candidate pancreatic cancer genes, selected from recurrently altered genomic loci, we performed a pooled shRNA library screen of cell growth/viability across 10 different cell lines. Knockdown-associated effects on cell growth were assessed by enrichment or depletion of shRNA hairpins, by hybridization to barcode microarrays. A novel analytical approach (COrrelated Phenotypes for On-Target Effects; COPOTE) was used to discern probable on-target knockdown, based on identifying different shRNAs targeting the same gene and displaying concordant phenotypes across cell lines. Knockdown data were integrated with genomic architecture and gene-expression profiles, and selected findings validated using individual shRNAs and/or independent siRNAs. The pooled shRNA library design delivered reproducible data. In all, COPOTE analysis identified 52 probable on-target gene-knockdowns. Knockdown of known oncogenes (KRAS, MYC, SMURF1 and CCNE1) and a tumor suppressor (CDKN2A) showed the expected contrasting effects on cell growth. In addition, the screen corroborated purported roles of PLEKHG2 and MED29 as 19q13 amplicon drivers. Most notably, the analysis also revealed novel possible oncogenic functions of nucleoporin NUP153 (ostensibly by modulating TGF beta signaling) and Kruppel-like transcription factor KLF5 in pancreatic cancer. Conclusions: By integrating physical and functional genomic data, we were able to simultaneously evaluate many candidate pancreatic cancer genes. Our findings uncover new facets of pancreatic cancer biology, with possible therapeutic implications. More broadly, our study provides a general strategy for the efficient characterization of candidate genes emerging from cancer genome studies.
引用
收藏
页数:13
相关论文
共 43 条
  • [1] Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer
    Azorsa, David O.
    Gonzales, Irma M.
    Basu, Gargi D.
    Choudhary, Ashish
    Arora, Shilpi
    Bisanz, Kristen M.
    Kiefer, Jeffrey A.
    Henderson, Meredith C.
    Trent, Jeffrey M.
    Von Hoff, Daniel D.
    Mousses, Spyro
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2009, 7
  • [2] Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
    Biankin, Andrew V.
    Waddell, Nicola
    Kassahn, Karin S.
    Gingras, Marie-Claude
    Muthuswamy, Lakshmi B.
    Johns, Amber L.
    Miller, David K.
    Wilson, Peter J.
    Patch, Ann-Marie
    Wu, Jianmin
    Chang, David K.
    Cowley, Mark J.
    Gardiner, Brooke B.
    Song, Sarah
    Harliwong, Ivon
    Idrisoglu, Senel
    Nourse, Craig
    Nourbakhsh, Ehsan
    Manning, Suzanne
    Wani, Shivangi
    Gongora, Milena
    Pajic, Marina
    Scarlett, Christopher J.
    Gill, Anthony J.
    Pinho, Andreia V.
    Rooman, Ilse
    Anderson, Matthew
    Holmes, Oliver
    Leonard, Conrad
    Taylor, Darrin
    Wood, Scott
    Xu, Qinying
    Nones, Katia
    Fink, J. Lynn
    Christ, Angelika
    Bruxner, Tim
    Cloonan, Nicole
    Kolle, Gabriel
    Newell, Felicity
    Pinese, Mark
    Mead, R. Scott
    Humphris, Jeremy L.
    Kaplan, Warren
    Jones, Marc D.
    Colvin, Emily K.
    Nagrial, Adnan M.
    Humphrey, Emily S.
    Chou, Angela
    Chin, Venessa T.
    Chantrill, Lorraine A.
    [J]. NATURE, 2012, 491 (7424) : 399 - 405
  • [3] A possible tumor suppressor role of the KLF5 transcription factor in human breast cancer
    Chen, C
    Bhalala, HV
    Qiao, H
    Dong, JT
    [J]. ONCOGENE, 2002, 21 (43) : 6567 - 6572
  • [4] KLF5 is frequently deleted and down-regulated but rarely mutated in prostate cancer
    Chen, C
    Bhalala, HV
    Vessella, RL
    Dong, JT
    [J]. PROSTATE, 2003, 55 (02) : 81 - 88
  • [5] Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer
    Cheung, Hiu Wing
    Cowley, Glenn S.
    Weir, Barbara A.
    Boehm, Jesse S.
    Rusin, Scott
    Scott, Justine A.
    East, Alexandra
    Ali, Levi D.
    Lizotte, Patrick H.
    Wong, Terence C.
    Jiang, Guozhi
    Hsiao, Jessica
    Mermel, Craig H.
    Getz, Gad
    Barretina, Jordi
    Gopal, Shuba
    Tamayo, Pablo
    Gould, Joshua
    Tsherniak, Aviad
    Stransky, Nicolas
    Luo, Biao
    Ren, Yin
    Drapkin, Ronny
    Bhatia, Sangeeta N.
    Mesirov, Jill P.
    Garraway, Levi A.
    Meyerson, Matthew
    Lander, Eric S.
    Root, David E.
    Hahn, William C.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (30) : 12372 - 12377
  • [6] Making sense of cancer genomic data
    Chin, Lynda
    Hahn, William C.
    Getz, Gad
    Meyerson, Matthew
    [J]. GENES & DEVELOPMENT, 2011, 25 (06) : 534 - 555
  • [7] From cancer genomes to oncogenic drivers, tumour dependencies and therapeutic targets
    Eifert, Cheryl
    Powers, R. Scott
    [J]. NATURE REVIEWS CANCER, 2012, 12 (08) : 572 - 578
  • [8] Functional Parsing of Driver Mutations in the Colorectal Cancer Genome Reveals Numerous Suppressors of Anchorage-Independent Growth
    Eskiocak, Ugur
    Kim, Sang Bum
    Ly, Peter
    Roig, Andres I.
    Biglione, Sebastian
    Komurov, Kakajan
    Cornelius, Crystal
    Wright, Woodring E.
    White, Michael A.
    Shay, Jerry W.
    [J]. CANCER RESEARCH, 2011, 71 (13) : 4359 - 4365
  • [9] Breakpoint Analysis of Transcriptional and Genomic Profiles Uncovers Novel Gene Fusions Spanning Multiple Human Cancer Types
    Giacomini, Craig P.
    Sun, Steven
    Varma, Sushama
    Shain, A. Hunter
    Giacomini, Marilyn M.
    Balagtas, Jay
    Sweeney, Robert T.
    Lai, Everett
    Del Vecchio, Catherine A.
    Forster, Andrew D.
    Clarke, Nicole
    Montgomery, Kelli D.
    Zhu, Shirley
    Wong, Albert J.
    van de Rijn, Matt
    West, Robert B.
    Pollack, Jonathan R.
    [J]. PLOS GENETICS, 2013, 9 (04):
  • [10] Probing the human kinome for kinases involved in pancreatic cancer cell survival and gemcitabine resistance
    Giroux, Valentin
    Iovanna, Juan
    Dagorn, Jean-Charles
    [J]. FASEB JOURNAL, 2006, 20 (12) : 1982 - 1991